Developing innovative therapeutic and prophylactic products that harness the power of the immune system to treat cancer, allergy, asthma and infectious diseases, and help accelerate recovery of the immune system after cancer chemotherapies.
The new Benaroya Research Institute at Virginia Mason is a state-of-the-art facility built specifically for collaborative biomedical research.
RxIBR is bringing innovations, Targeted Biologic Therapy from the Institute of Biologic Research into commercial fruition.
Originators of clinical saliva testing for female and male hormones.
Research company and institute dedicated to the discovery of novel drugs and therapeutics for diabetes, its complications, obesity, and related disorders.
Advanced evaluations, treatments, monitoring, education, for those with psychiatric and neurological diseases.
Early stage drug discovery opportunities, research expertise and facilities, and intellectual property available for licensing from the Strathclyde Institute for Drug Research, University of Strathclyde, Glasgow, Scotland.
Australian biomedical research company, which funds, manages, and commercialises diagnostic and therapeutic research projects including cancer diagnostic tests and antiviral agents.
The Leeds centre brings together more than 40 experts in biochemistry, chemistry, physics, biomedical science and clinical medicine to develop the new technology known as 'Photodynamics'.
Biomedical research and development company exploiting the interrelationship between neuroendocrine and immune systems to identify biological response modifiers enhancing immune function for the treatment of cancer.
|